AI hype fuels the flames. Machines learning to outthink humans? A siren song for investors. The Fed’s rate cuts? A back-alley deal to keep the party going. Lower rates mean cheaper loans, more hiring, more mergers. Sounds clean until you realize the ink’s still wet on the contracts.
Admittedly, the entire market smells like overpriced salmon (by historical standards). AI’s alleged “profound economic impact” is the corporate world’s version of a New Year’s resolution: ambitious, vaguely defined, and mostly a way to justify burning money. Meanwhile, quantum computing? That’s the office weirdo who shows up in a hazmat suit, claims they’re “revolutionizing entanglement,” and then asks for a raise.
Look closer. Beneath the polished metrics lies the truth: it is not about returns. It is about who holds the shovel. VCSH, larger, colder, with $46.2 billion in cold muscle, moves slow and silent like a glacier. IGSB, half its size, humbler in stature, spreads its holdings wider-4,435 names against 2,552. More bonds. More diversification. As if scattering seeds on stone ground will make them grow.
This stake, now 5.53% of the firm’s 13F reportable assets, crouches third on their portfolio’s throne. The numbers, like a ledger’s ghost, whisper of a calculated gambit-perhaps the scent of AI-driven loans or the faint hope that a lawsuit might one day dissolve like morning mist.
Westshore’s acquisition, constituting 4.73% of its 13F reportable assets, was no casual dalliance. The firm, whose portfolio bore the weight of $292 million in U.S. equities, now found itself tethered to Amneal’s fortunes-a bond forged in the crucible of risk and calculation. The transaction placed Amneal as the sixth-largest holding, a position outside the top five, yet one that whispered of ambition. One might ponder: does this quiet entry signify a strategist’s foresight, or merely the latest ripple in the ceaseless tide of market speculation?
Once christened with the forgettable name of Atlantic Crypto, the entity that would become CoreWeave embarked on a noble quest: to harness the power of Nvidia’s GPUs in the pursuit of Ethereum mining. Yet, like the fleeting hope of a gambler winning his fortune on the turn of a card, this venture too fell to the unforgiving winds of profit loss. But the company was no fool-like all ambitious adventurers, it pivoted. The once glittering dream of mining morphed into the dull, pragmatic realm of cloud computing, a steady business where one could rent out the very hardware once used to chase digital gold. And so, with promises of speed and cost-efficiency, CoreWeave pitched its services to other dreamers in need of raw computational power.
On the 14th of November, a U.S. Securities and Exchange Commission filing doth reveal that MPM BioImpact hath divested its entire holding in MoonLake Immunotherapeutics (MLTX 0.51%) during the third quarter. The fund parted with 313,571 shares, erasing a position that once constituted 2.6% of its assets under management. This transaction, valued at an estimated $14.8 million, doth mark a dramatic retreat from a once-promising venture.
Investors, ever the seekers of refuge in turbulent times, have turned to Bitcoin as one might to a rusted door in a crumbling house. The broader financial landscape, with its flickering candle of optimism for AI-driven equities and the NASDAQ, has lent an air of cautious hope. Yet beneath this surface, the true architects of Bitcoin’s revival are not the macroeconomic winds but the quiet, persistent forces of monetary alchemy and cyclical inevitability.
Let’s get this straight: Federated Hermes is now 16.37% of Schneider Downs’ AUM. That’s not a position. That’s a domination. The fund’s top five holdings read like a bingo card for institutional mania. NYSE: FHI ($137.99M), NYSEMKT: SPDW ($73.82M), VO ($69.96M), MMIT ($54.48M), SCHG ($51.18M). The stock itself? Trading at $49.16 as of Nov. 16, up 20.49% year-over-year. Outperforming the S&P 500 by 9.02 percentage points. Is this a stock? Or is it a hallucination birthed from the SEC’s red tape and a caffeine addiction?
Bear witness to its lineage: Nebius emerged from the fractured remains of Yandex, that Russian search monolith expelled from Nasdaq’s temple when the cannons of Ukraine’s siege roared. Conceived as Yandex’s internal GPU-laden hydra, it now rears its head in Amsterdam’s financial courts, reborn as a so-called “neocloud” apostle alongside CoreWeave. Their creed? To furnish the electrum of AI-Nvidia’s sacred GPUs-upon demand, mirroring Amazon’s AWS dominion yet dedicated to the algorithmic sublime. A noble cause, or so the prospectuses claim.